<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Appl Thromb Hemost</journal-id><journal-id journal-id-type="iso-abbrev">Clin Appl Thromb Hemost</journal-id><journal-id journal-id-type="pmc-domain-id">3706</journal-id><journal-id journal-id-type="pmc-domain">cathromb</journal-id><journal-id journal-id-type="publisher-id">CAT</journal-id><journal-title-group><journal-title>Clinical and Applied Thrombosis/Hemostasis</journal-title></journal-title-group><issn pub-type="ppub">1076-0296</issn><issn pub-type="epub">1938-2723</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11334244</article-id><article-id pub-id-type="pmcid-ver">PMC11334244.1</article-id><article-id pub-id-type="pmcaid">11334244</article-id><article-id pub-id-type="pmcaiid">11334244</article-id><article-id pub-id-type="pmid">39161215</article-id><article-id pub-id-type="doi">10.1177/10760296241276524</article-id><article-id pub-id-type="publisher-id">10.1177_10760296241276524</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title>Development and Validation of a Nomogram Model for Predicting in-Hospital Mortality in non-Diabetic Patients with non-ST-Segment Elevation Acute Myocardial Infarction</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0001-0203-6547</contrib-id><name name-style="western"><surname>Li</surname><given-names initials="P">Panpan</given-names></name><degrees>MS</degrees><xref rid="aff1-10760296241276524" ref-type="aff">1</xref><xref rid="aff2-10760296241276524" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7151-4293</contrib-id><name name-style="western"><surname>Yao</surname><given-names initials="W">Wensen</given-names></name><degrees>MD</degrees><xref rid="aff3-10760296241276524" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="J">Jingjing</given-names></name><degrees>MS</degrees><xref rid="aff1-10760296241276524" ref-type="aff">1</xref><xref rid="aff2-10760296241276524" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="Y">Yating</given-names></name><degrees>MS</degrees><xref rid="aff3-10760296241276524" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="X">Xueyuan</given-names></name><degrees>MS</degrees><xref rid="aff3-10760296241276524" ref-type="aff">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hu</surname><given-names initials="W">Wei</given-names></name><degrees>MD</degrees><xref rid="aff1-10760296241276524" ref-type="aff">1</xref><xref rid="corresp1-10760296241276524" ref-type="corresp"/></contrib></contrib-group><aff id="aff1-10760296241276524">
<label>1</label>Department of Cardiovascular Medicine, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei Province, China</aff><aff id="aff2-10760296241276524">
<label>2</label>College of Medicine, <institution-wrap><institution-id institution-id-type="Ringgold">47900</institution-id><institution content-type="university">Wuhan University of Science and Technology</institution></institution-wrap>, Wuhan, Hubei Province, China</aff><aff id="aff3-10760296241276524">
<label>3</label>Department of Geriatrics and Special Medical Treatment, <institution-wrap><institution-id institution-id-type="Ringgold">117971</institution-id><institution content-type="university">The First Hospital of Jilin University</institution></institution-wrap>, Changchun, China</aff><author-notes><corresp id="corresp1-10760296241276524">Wei Hu, Department of Cardiovascular Medicine, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, The Central Hospital of Xiaogan, No. 6 Plaza Street, Xiaogan 432000, Hubei Province, China. 
Email: <email>hwhd611@163.com</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="collection"><season>Jan-Dec</season><year>2024</year></pub-date><volume>30</volume><issue-id pub-id-type="pmc-issue-id">452621</issue-id><elocation-id>10760296241276524</elocation-id><history><date date-type="received"><day>17</day><month>5</month><year>2024</year></date><date date-type="rev-recd"><day>29</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>1</day><month>8</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>08</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>20</day><month>08</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-29 00:25:24.453"><day>29</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder content-type="sage">SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_10760296241276524.pdf"/><abstract><p>Non-ST-segment elevation acute myocardial infarction (NSTEMI) is a life-threatening clinical emergency with a poor prognosis. However, there are no individualized nomogram models to identify patients at high risk of NSTEMI who may undergo death. The aim of this study was to develop a nomogram for in-hospital mortality in patients with NSTEMI to facilitate rapid risk stratification of patients. A total of 774 non-diabetic patients with NSTEMI were included in this study. Least Absolute Shrinkage and Selection Operator regression was used to initially screen potential predictors. Univariate and multivariate logistic regression (backward stepwise selection) analyses were performed to identify the optimal predictors for the prediction model. The corresponding nomogram was constructed based on those predictors. The receiver operating characteristic curve, GiViTI calibration plot, and decision curve analysis (DCA) were used to evaluate the performance of the nomogram. The nomogram model consisting of six predictors: age (OR&#8201;=&#8201;1.10; 95% CI: 1.05-1.15), blood urea nitrogen (OR&#8201;=&#8201;1.06; 95% CI: 1.00-1.12), albumin (OR&#8201;=&#8201;0.93; 95% CI: 0.87-1.00), triglyceride (OR&#8201;=&#8201;1.41; 95% CI: 1.09-2.00), D-dimer (OR&#8201;=&#8201;1.39; 95% CI: 1.06-1.80), and aspirin (OR&#8201;=&#8201;0.16; 95% CI: 0.06-0.42). The nomogram had good discrimination (area under the curve (AUC)&#8201;=&#8201;0.89, 95% CI: 0.84-0.94), calibration, and clinical usefulness. In this study, we developed a nomogram model to predict in-hospital mortality in patients with NSTEMI based on common clinical indicators. The proposed nomogram has good performance, allowing rapid risk stratification of patients with NSTEMI.</p></abstract><kwd-group><kwd>non-ST-segment elevation acute myocardial infarction</kwd><kwd>prediction model</kwd><kwd>in-hospital mortality</kwd><kwd>blood urea nitrogen</kwd><kwd>D-dimer</kwd></kwd-group><funding-group specific-use="FundRef"><award-group id="award1-10760296241276524"><funding-source id="funding1-10760296241276524"><institution-wrap><institution>Hubei Provincial Key Laboratory of Occupational Hazard Identification and Control</institution></institution-wrap></funding-source><award-id rid="funding1-10760296241276524">JF2023-G10</award-id></award-group><award-group id="award2-10760296241276524"><funding-source id="funding2-10760296241276524"><institution-wrap><institution>Hubei Provincial Health Commission Joint Fund</institution></institution-wrap></funding-source><award-id rid="funding2-10760296241276524">WJ2018H0094</award-id></award-group><award-group id="award3-10760296241276524"><funding-source id="funding3-10760296241276524"><institution-wrap><institution>Xiaogan Natural Science Program</institution></institution-wrap></funding-source><award-id rid="funding3-10760296241276524">XGKJ2020010005</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts19</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section1-10760296241276524"><title>Introduction</title><p>Cardiovascular deaths have long been the leading cause of death globally. in 2021, cardiovascular diseases were responsible for an estimated 19.91 million deaths globally.<sup>
<xref rid="bibr1-10760296241276524" ref-type="bibr">1</xref>
</sup> Non-ST-segment elevation acute myocardial infarction (NSTEMI) is one of the leading causes of hospitalization in patients with ischemic heart disease and is associated with a high mortality rate.<sup>
<xref rid="bibr2-10760296241276524" ref-type="bibr">2</xref>
</sup> Data from the Beijing region of China showed that the hospitalization rate for NSTEMI per 100,000 population almost tripled from 2007 to 2012 (from 8.1% to 33.5%), with in-hospital mortality rates decreasing from 6.4 to 5.3% for men and from 11.6 to 8.7% for women.<sup>
<xref rid="bibr3-10760296241276524" ref-type="bibr">3</xref>
</sup> A recent study showed that the 30-day mortality rate for NSTEMI in China was reported to be 4.7%, with the highest proportion of in-hospital deaths.<sup>
<xref rid="bibr4-10760296241276524" ref-type="bibr">4</xref>
</sup> Treatment of NSTEMI consists mainly of pharmacologic and invasive therapies.<sup>
<xref rid="bibr5-10760296241276524" ref-type="bibr">5</xref>
</sup> Antiplatelet drug therapy is usually performed in all patients, and the main drugs include aspirin and clopidogrel. Percutaneous coronary intervention is an effective treatment for NSTEMI in patients with ineffective pharmacologic therapy or at high risk for NSTEMI (eg, intractable angina, heart failure, ventricular tachycardia or ventricular fibrillation, and new onset of ST-segment depression).<sup>
<xref rid="bibr5-10760296241276524" ref-type="bibr">5</xref>
</sup></p><p>Improving the prognosis of patients with NSTEMI and especially reducing in-hospital mortality is a long-term challenge for emergency physicians and cardiologists. Adherence to risk stratification of the disease and individualization of treatment are key to addressing this issue. The Thrombolysis in Myocardial Infarction and Global Registry of Acute Coronary Events risk scores were developed primarily in patients of Caucasian origin and are often used to assess adverse events and prognosis in NSTEMI.<sup><xref rid="bibr6-10760296241276524" ref-type="bibr">6</xref>,<xref rid="bibr7-10760296241276524" ref-type="bibr">7</xref></sup> However, they have been reported to have limited applicability in non-White ethnicity.<sup><xref rid="bibr8-10760296241276524" ref-type="bibr">8</xref>,<xref rid="bibr9-10760296241276524" ref-type="bibr">9</xref></sup> Yang et al first proposed a risk prediction model for in-hospital mortality in Chinese NSTEMI patients in 2018, which showed good predictive results, but systematic model validation was lacking, and it has not been widely studied since then.<sup>
<xref rid="bibr10-10760296241276524" ref-type="bibr">10</xref>
</sup> Individualized risk assessment of patients to determine treatment regimens and overall management approaches is expected to result in lower mortality rates and better short- and long-term clinical outcomes. In recent years, the nomogram models have been widely used in disease diagnosis and risk stratification due to their visualization and simplicity. A well-performing nomogram can positively influence clinical decision-making and patient prognosis to a certain extent. Here we present a nomogram prediction model for hazard stratification of the risk of in-hospital death in patients with NSTEMI to help clinicians improve the prognosis of NSTEMI.</p></sec><sec sec-type="methods" id="section2-10760296241276524"><title>Methods</title><sec id="section2A-10760296241276524"><title>Data Source</title><p>Data for this retrospective study were obtained from a publicly available dataset (data available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://peerj.com/articles/14346/" ext-link-type="uri">https://peerj.com/articles/14346/</ext-link>), which was shared by Yao et al.<sup>
<xref rid="bibr11-10760296241276524" ref-type="bibr">11</xref>
</sup> All authors have waived their copyright to the original research data. For scientific research purposes, we used these data for secondary analysis.</p></sec><sec id="section2B-10760296241276524"><title>Study Population</title><p>A total of 774 non-diabetic patients diagnosed with NSTEMI were included in this study, including 734 patients who survived to discharge and 40 who died during their hospitalization. The Ethics Committee of Zhongda Hospital affiliated to Southeast University (2020ZDSYLL164-P01) approved the original study.</p></sec><sec id="section2C-10760296241276524"><title>Data Collection</title><p>We included a set of variables based on literature review and their availability in the original dataset. These variables include age, sex, hypertension, chronic kidney disease (CKD), smoking, alcohol, systolic blood pressure (SBP), diastolic blood pressure (DBP), Pulse, white blood cells (WBC), neutrophils, lymphocytes, monocytes, platelet (PLT), hemoglobin (Hb), D-dimer, alanine aminotransferase (ALT), aspartate aminotransferase (AST); albumin (ALB), lactate dehydrogenase (LDH), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, triglyceride (TG), total cholesterol (TC), blood urea nitrogen (BUN), uric acid (UA), creatinine, cardiac troponin I (cTnI), left ventricular ejected fraction (LVEF), antihypertensive drug, lipid-lowering drug, aspirin, diuretics and &#946;-blockers.</p></sec><sec id="section2D-10760296241276524"><title>Statistical Analyses</title><p>The distributions of all quantitative variables were analyzed using the Shapiro-Wilk test. Normally distributed continuous data were presented as the mean&#8201;&#177; standard deviation and were compared between the two groups using the independent samples t-test. Non-normally distributed continuous data were presented as median (interquartile range) and compared using the Mann-Whitney test. Categorical variables were presented as counts and percentages, and differences between two groups were compared by the chi-squared test or the Fisher exact test.</p><p><xref rid="fig1-10760296241276524" ref-type="fig">Figure 1</xref> illustrated the flowchart of this study. All the 774 patients were analyzed for variable selection to develop the risk prediction model. Least Absolute Shrinkage and Selection Operator (LASSO) regression was applied to select the potential predictors from 34 candidate variables. Univariate logistic regression and multivariate backward stepwise logistic regression were performed to identify the predictors for in-hospital mortality in patients with NSTEMI, and the Akaike Information Criterion (AIC) was used to construct the best prediction model. A nomogram was developed based on the results of the best prediction model, which was validated internally using the bootstrap method. The receiver operating characteristic (ROC) curve, GiViTI calibration plot, and decision curve analysis (DCA) were used to evaluate the performance of the nomogram. All of the statistical analyses were performed using R software (4.2.2). A <italic toggle="yes">P</italic>-value &lt;&#8201;.05 (two-tailed) or the 95% confidence interval (CI) of the odds ratio excluding the value one was considered statistically significant.</p><fig position="float" id="fig1-10760296241276524" orientation="portrait"><label>Figure 1.</label><caption><p>Research flow chart.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10760296241276524-fig1.jpg"/></fig></sec></sec><sec sec-type="results" id="section3-10760296241276524"><title>Results</title><sec id="section3A-10760296241276524"><title>Baseline Characteristics</title><p>A total of 774 eligible patients were enrolled in this study, 734 of them survived to discharge and 40 died during their hospitalization. The baseline characteristics of the included participants are presented in <xref rid="table1-10760296241276524" ref-type="table">Table 1</xref>. NSTEMI patients who die in-hospital tend to be older, more likely to have comorbid CKD, have lower SBP and DBP, faster pulse rates, and lower LVEF than those who survive to discharge (all <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05). In terms of laboratory tests, NSTEMI patients who died in-hospital had higher WBC counts, neutrophil counts, D-dimer, LDH, BUN, and creatinine, and lower lymphocyte counts, Hb, ALB, LDL-C, and TC (all <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05). In terms of medication use, patients who died in the hospital had significantly lower rates of use of antihypertensive drugs, lipid-lowering drugs, aspirin, diuretics, and &#946;-blockers than those who survived (all <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05).</p><table-wrap position="float" id="table1-10760296241276524" orientation="portrait"><label>Table 1.</label><caption><p>Baseline Characteristics of Patients with NSTEMI.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10760296241276524-table1.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">All Patients<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;774)</th><th align="left" rowspan="1" colspan="1">Survival Group<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;734)</th><th align="left" rowspan="1" colspan="1">Death Group<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;40)</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (y)</td><td rowspan="1" colspan="1">76.00 [64.00, 85.00]</td><td rowspan="1" colspan="1">75.00 [64.00, 84.00]</td><td rowspan="1" colspan="1">86.50 [82.75, 91.00]</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">Female, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">243 (31.4)</td><td rowspan="1" colspan="1">225 (30.7)</td><td rowspan="1" colspan="1">18 (45.0)</td><td rowspan="1" colspan="1">.084</td></tr><tr><td rowspan="1" colspan="1">Hypertension, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">554 (71.6)</td><td rowspan="1" colspan="1">522 (71.1)</td><td rowspan="1" colspan="1">32 (80.0)</td><td rowspan="1" colspan="1">.302</td></tr><tr><td rowspan="1" colspan="1">CKD, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">65 (8.4)</td><td rowspan="1" colspan="1">57 (7.8)</td><td rowspan="1" colspan="1">8 (20.0)</td><td rowspan="1" colspan="1">.015</td></tr><tr><td rowspan="1" colspan="1">Smoking, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">289 (37.3)</td><td rowspan="1" colspan="1">280 (38.1)</td><td rowspan="1" colspan="1">9 (22.5)</td><td rowspan="1" colspan="1">.068</td></tr><tr><td rowspan="1" colspan="1">Alcohol, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">107 (13.8)</td><td rowspan="1" colspan="1">106 (14.4)</td><td rowspan="1" colspan="1">1 (2.5)</td><td rowspan="1" colspan="1">.058</td></tr><tr><td rowspan="1" colspan="1">SBP (mm&#8201;Hg)</td><td rowspan="1" colspan="1">133.00 [120.00, 146.00]</td><td rowspan="1" colspan="1">134.00 [120.00, 146.00]</td><td rowspan="1" colspan="1">126.00 [105.50, 137.25]</td><td rowspan="1" colspan="1">.003</td></tr><tr><td rowspan="1" colspan="1">DBP (mm&#8201;Hg)</td><td rowspan="1" colspan="1">80.00 [70.00, 86.00]</td><td rowspan="1" colspan="1">80.00 [70.00, 86.00]</td><td rowspan="1" colspan="1">75.00 [60.00, 82.00]</td><td rowspan="1" colspan="1">.022</td></tr><tr><td rowspan="1" colspan="1">Pulse (beats/min)</td><td rowspan="1" colspan="1">76.00 [68.00, 85.00]</td><td rowspan="1" colspan="1">75.00 [68.00, 84.00]</td><td rowspan="1" colspan="1">83.50 [68.75, 97.00]</td><td rowspan="1" colspan="1">.025</td></tr><tr><td rowspan="1" colspan="1">WBC (10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">7.40 [6.10, 9.44]</td><td rowspan="1" colspan="1">7.35 [6.08, 9.37]</td><td rowspan="1" colspan="1">8.60 [6.60, 11.73]</td><td rowspan="1" colspan="1">.012</td></tr><tr><td rowspan="1" colspan="1">Neutrophils (10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">5.33 [4.05, 7.48]</td><td rowspan="1" colspan="1">5.30 [4.01, 7.32]</td><td rowspan="1" colspan="1">6.64 [4.80, 10.53]</td><td rowspan="1" colspan="1">.003</td></tr><tr><td rowspan="1" colspan="1">Lymphocytes (10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">1.33 [0.95, 1.76]</td><td rowspan="1" colspan="1">1.35 [0.97, 1.77]</td><td rowspan="1" colspan="1">0.82 [0.61, 1.46]</td><td rowspan="1" colspan="1">.001</td></tr><tr><td rowspan="1" colspan="1">Monocytes (10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">0.43 [0.32, 0.56]</td><td rowspan="1" colspan="1">0.43 [0.32, 0.56]</td><td rowspan="1" colspan="1">0.48 [0.33, 0.56]</td><td rowspan="1" colspan="1">.442</td></tr><tr><td rowspan="1" colspan="1">PLT (10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">187.00 [149.00, 229.00]</td><td rowspan="1" colspan="1">187.00 [151.00, 229.00]</td><td rowspan="1" colspan="1">183.50 [137.50, 234.50]</td><td rowspan="1" colspan="1">.298</td></tr><tr><td rowspan="1" colspan="1">Hb (g/L)</td><td rowspan="1" colspan="1">132.00 [115.00, 146.75]</td><td rowspan="1" colspan="1">133.00 [117.00, 147.00]</td><td rowspan="1" colspan="1">112.00 [97.00, 124.75]</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">D-dimer (mg/L)</td><td rowspan="1" colspan="1">0.18 [0.08, 0.47]</td><td rowspan="1" colspan="1">0.17 [0.08, 0.44]</td><td rowspan="1" colspan="1">0.59 [0.26, 1.26]</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">ALT (U/L)</td><td rowspan="1" colspan="1">24.00 [16.00, 35.00]</td><td rowspan="1" colspan="1">24.00 [16.00, 35.00]</td><td rowspan="1" colspan="1">30.00 [13.00, 38.25]</td><td rowspan="1" colspan="1">.221</td></tr><tr><td rowspan="1" colspan="1">AST (U/L)</td><td rowspan="1" colspan="1">33.00 [22.00, 63.00]</td><td rowspan="1" colspan="1">32.50 [22.00, 62.00]</td><td rowspan="1" colspan="1">47.50 [21.75, 128.75]</td><td rowspan="1" colspan="1">.055</td></tr><tr><td rowspan="1" colspan="1">ALB (g/L)</td><td rowspan="1" colspan="1">37.25 [34.00, 40.20]</td><td rowspan="1" colspan="1">37.60 [34.35, 40.40]</td><td rowspan="1" colspan="1">33.90 [28.40, 37.00]</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">LDH (U/L)</td><td rowspan="1" colspan="1">237.00 [179.25, 321.00]</td><td rowspan="1" colspan="1">235.00 [178.25, 309.75]</td><td rowspan="1" colspan="1">300.00 [199.25, 507.50]</td><td rowspan="1" colspan="1">.010</td></tr><tr><td rowspan="1" colspan="1">LDL-C (mmol/L)</td><td rowspan="1" colspan="1">2.64 [2.08, 3.17]</td><td rowspan="1" colspan="1">2.65 [2.11, 3.18]</td><td rowspan="1" colspan="1">2.24 [1.74, 2.83]</td><td rowspan="1" colspan="1">.004</td></tr><tr><td rowspan="1" colspan="1">HDL-C (mmol/L)</td><td rowspan="1" colspan="1">1.06 [0.91, 1.23]</td><td rowspan="1" colspan="1">1.06 [0.92, 1.22]</td><td rowspan="1" colspan="1">0.97 [0.77, 1.24]</td><td rowspan="1" colspan="1">.067</td></tr><tr><td rowspan="1" colspan="1">TG (mmol/L)</td><td rowspan="1" colspan="1">1.30 [0.93, 1.79]</td><td rowspan="1" colspan="1">1.30 [0.93, 1.79]</td><td rowspan="1" colspan="1">1.42 [0.98, 1.74]</td><td rowspan="1" colspan="1">.404</td></tr><tr><td rowspan="1" colspan="1">TC (mmol/L)</td><td rowspan="1" colspan="1">4.31 [3.61, 5.01]</td><td rowspan="1" colspan="1">4.34 [3.64, 5.01]</td><td rowspan="1" colspan="1">3.83 [3.14, 4.68]</td><td rowspan="1" colspan="1">.017</td></tr><tr><td rowspan="1" colspan="1">BUN (mmol/L)</td><td rowspan="1" colspan="1">6.10 [4.70, 8.20]</td><td rowspan="1" colspan="1">5.90 [4.70, 7.88]</td><td rowspan="1" colspan="1">10.35 [8.52, 14.23]</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">UA (&#181;mol/L)</td><td rowspan="1" colspan="1">351.50 [282.00, 424.00]</td><td rowspan="1" colspan="1">350.00 [282.00, 421.00]</td><td rowspan="1" colspan="1">360.00 [263.75, 478.00]</td><td rowspan="1" colspan="1">.449</td></tr><tr><td rowspan="1" colspan="1">Creatinine (&#181;mol/L)</td><td rowspan="1" colspan="1">87.50 [70.00, 112.00]</td><td rowspan="1" colspan="1">86.50 [69.00, 109.00]</td><td rowspan="1" colspan="1">128.50 [104.50, 210.25]</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">cTnI (ng/mL)</td><td rowspan="1" colspan="1">0.66 [0.12, 3.09]</td><td rowspan="1" colspan="1">0.64 [0.12, 2.91]</td><td rowspan="1" colspan="1">1.55 [0.16, 6.94]</td><td rowspan="1" colspan="1">.102</td></tr><tr><td rowspan="1" colspan="1">LVEF (%)</td><td rowspan="1" colspan="1">63.00 [53.00, 70.00]</td><td rowspan="1" colspan="1">63.00 [54.00, 70.00]</td><td rowspan="1" colspan="1">55.00 [43.75, 65.25]</td><td rowspan="1" colspan="1">.002</td></tr><tr><td rowspan="1" colspan="1">Antihypertensive drug, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">540 (69.8)</td><td rowspan="1" colspan="1">524 (71.4)</td><td rowspan="1" colspan="1">16 (40.0)</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">Lipid-lowering drug, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">732 (94.6)</td><td rowspan="1" colspan="1">704 (95.9)</td><td rowspan="1" colspan="1">28 (70.0)</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">Aspirin, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">738 (95.3)</td><td rowspan="1" colspan="1">710 (96.7)</td><td rowspan="1" colspan="1">28 (70.0)</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td rowspan="1" colspan="1">Diuretics, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">288 (37.2)</td><td rowspan="1" colspan="1">280 (38.1)</td><td rowspan="1" colspan="1">8 (20.0)</td><td rowspan="1" colspan="1">.032</td></tr><tr><td rowspan="1" colspan="1">&#946;-blockers, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1">625 (80.7)</td><td rowspan="1" colspan="1">605 (82.4)</td><td rowspan="1" colspan="1">20 (50.0)</td><td rowspan="1" colspan="1">&lt;.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-10760296241276524"><p>Note: Data are presented as the <italic toggle="yes">n</italic> (%) or median (25th Percentile, 75th Percentile).</p></fn><fn id="table-fn2-10760296241276524"><p>Abbreviations: NSTEMI, non-ST-segment elevation acute myocardial infarction; CKD, chronic kidney disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cells; PLT, platelet; Hb, hemoglobin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALB, albumin; LDH, lactate dehydrogenase; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; TC, total cholesterol; BUN, blood urea nitrogen; UA, uric acid; cTnI, cardiac troponin I; LVEF, left ventricular ejected fraction.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section3B-10760296241276524"><title>Variable Selection Based on the LASSO Regression</title><p>LASSO regression was used to initially screen the predictors. The LASSO regression included 34 candidate variables (all variables in <xref rid="table1-10760296241276524" ref-type="table">Tables 1</xref>), and based on the result of the LASSO regression analysis, we screened the following seven variables with non-zero coefficients as predictors: age, BUN, ALB, TG, D-dimer, Aspirin and Lipid-lowering drug (<xref rid="fig2-10760296241276524" ref-type="fig">Figure 2</xref>).</p><fig position="float" id="fig2-10760296241276524" orientation="portrait"><label>Figure 2.</label><caption><p>Feature selection using the least absolute shrinkage and selection operator (LASSO) binary logistic regression model. (A) LASSO coefficient profiles of the 34 baseline features; (B) The tuning parameter (&#955;) selection in the LASSO model using 10-fold cross-validation via minimum criteria. Vertical lines were drawn at the value selected using 10-fold cross-validation, where optimal &#955; resulted in 7 non-zero coefficients.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10760296241276524-fig2.jpg"/></fig></sec><sec id="section3C-10760296241276524"><title>Univariate and Multivariate Logistic Regression Analysis</title><p>As shown in <xref rid="table2-10760296241276524" ref-type="table">Table 2</xref>, seven variables screened by LASSO regression were included in the univariate logistic regression analysis and those variables that were statistically significant (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05) in the univariate analysis were subsequently included in the multivariate logistic regression model in a backward stepwise fashion.</p><table-wrap position="float" id="table2-10760296241276524" orientation="portrait"><label>Table 2.</label><caption><p>Univariate and multivariate logistic regression analyses.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10760296241276524-table2.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="2" rowspan="1">Univariate Analysis</th><th align="left" colspan="2" rowspan="1">Multivariate Analysis</th></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">OR (95% CI)</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</th><th align="left" rowspan="1" colspan="1">OR (95% CI)</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (y)</td><td rowspan="1" colspan="1">1.11 (1.07-1.16)</td><td rowspan="1" colspan="1">&lt; .001</td><td rowspan="1" colspan="1">1.10 (1.05-1.15)</td><td rowspan="1" colspan="1">&lt; .001</td></tr><tr><td rowspan="1" colspan="1">BUN (mmol/L)</td><td rowspan="1" colspan="1">1.13 (1.08-1.17)</td><td rowspan="1" colspan="1">&lt; .001</td><td rowspan="1" colspan="1">1.06 (1.00-1.12)</td><td rowspan="1" colspan="1">.064</td></tr><tr><td rowspan="1" colspan="1">ALB (g/L)</td><td rowspan="1" colspan="1">0.86 (0.81-0.91)</td><td rowspan="1" colspan="1">&lt; .001</td><td rowspan="1" colspan="1">0.93 (0.87-1.00)</td><td rowspan="1" colspan="1">.041</td></tr><tr><td rowspan="1" colspan="1">TG (mmol/L)</td><td rowspan="1" colspan="1">1.36 (1.15-1.61)</td><td rowspan="1" colspan="1">&lt; 0.001</td><td rowspan="1" colspan="1">1.41 (1.09-2.00)</td><td rowspan="1" colspan="1">.035</td></tr><tr><td rowspan="1" colspan="1">D-dimer (mg/L)</td><td rowspan="1" colspan="1">1.60 (1.33-1.93)</td><td rowspan="1" colspan="1">&lt; .001</td><td rowspan="1" colspan="1">1.39 (1.06-1.80)</td><td rowspan="1" colspan="1">.015</td></tr><tr><td rowspan="1" colspan="1">Aspirin</td><td rowspan="1" colspan="1">0.08 (0.04-0.17)</td><td rowspan="1" colspan="1">&lt; .001</td><td rowspan="1" colspan="1">0.16 (0.06-0.42)</td><td rowspan="1" colspan="1">&lt; .001</td></tr><tr><td rowspan="1" colspan="1">Lipid-lowering drug</td><td rowspan="1" colspan="1">0.10 (0.05-0.21)</td><td rowspan="1" colspan="1">&lt; .001</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn3-10760296241276524"><p>Abbreviations: BUN, blood urea nitrogen; ALB, albumin; TG, triglyceride.</p></fn></table-wrap-foot></table-wrap><p>Finally, an optimal predictive model consisting of six variables (age, BUN, ALB, TG, D-dimer and Aspirin) was determined according to the AIC.</p></sec><sec id="section3D-10760296241276524"><title>Development and Validation of a Mortality-Predicting Nomogram</title><p>As shown in <xref rid="fig3-10760296241276524" ref-type="fig">Figure 3</xref>, a simple nomogram was formulated on the results of multivariate analysis to facilitate the calculation of risk scores and thus easily assess the probability of an individual's in-hospital mortality.</p><fig position="float" id="fig3-10760296241276524" orientation="portrait"><label>Figure 3.</label><caption><p>The nomogram for the prediction of in-hospital mortality in patients with NSTEMI.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10760296241276524-fig3.jpg"/><attrib>Abbreviations: BUN, blood urea nitrogen; ALB, albumin; TG, triglyceride.</attrib></fig><p>Each of these independent predictors was projected upwards onto the &#8216;point&#8217; of that value at the top of the nomogram to obtain a score from 0 to 100, and the total score of these points were then recorded to predict the probability of NSTEMI patients in-hospital mortality risk.</p><p>We evaluated the performance of the nomogram in the internal validation. ROC analysis showed that the developed nomogram model had good discriminatory power with a specificity of 86% and a sensitivity of 80%, corresponding to an area under the curve (AUC) of 0.89 (95% CI: 0.84-0.94) (<xref rid="fig4-10760296241276524" ref-type="fig">Figure 4</xref>).</p><fig position="float" id="fig4-10760296241276524" orientation="portrait"><label>Figure 4.</label><caption><p>The receiver operating characteristic (ROC) curve of the nomogram.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10760296241276524-fig4.jpg"/></fig><p>The 80% and 95% CI regions of the GiViTI calibration bands did not cover the 45 degree diagonal divider (<italic toggle="yes">P</italic>&#8201;=&#8201;.645), indicating the consistency of the model's predicted probabilities with the actual probabilities and the high reliability of the prediction model (<xref rid="fig5-10760296241276524" ref-type="fig">Figure 5A</xref>).</p><fig position="float" id="fig5-10760296241276524" orientation="portrait"><label>Figure 5.</label><caption><p>(A) The GiViTI calibration plot of nomogram model; (B) the clinical decision curve analysis (DCA) of nomogram model.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10760296241276524-fig5.jpg"/></fig><p>The DCA showed the clinical utility of the nomogram to predict in-hospital mortality of patients with NSTEMI (<xref rid="fig5-10760296241276524" ref-type="fig">Figure 5B</xref>). A horizontal line represents the intervention-none and the net benefit with zero, the oblique line shows intervention-all-patients. As can be seen from the results of the DCA, the nomogram provided substantial net benefits over this broad range of threshold probability ranged from 5% to 100%, suggesting that the model we developed provided sound clinical guidance.</p></sec></sec><sec sec-type="discussion" id="section4-10760296241276524"><title>Discussion</title><p>NSTEMI is a common cardiac emergency with a poor prognosis. However, previous studies on cardiovascular disease risk assessment and prognosis have focused mostly on ST-segment elevation myocardial infarction (STEMI), and NSTEMI has been relatively understudied. Recent epidemiological studies have shown a decreasing trend in the relative incidence of STEMI and a gradual increase in the incidence of NSTEMI.<sup><xref rid="bibr3-10760296241276524" ref-type="bibr">3</xref>,<xref rid="bibr12-10760296241276524" ref-type="bibr">12</xref></sup> Conducting relevant research on NSTEMI could help improve prognosis and reduce the economic burden. Our aim of this study was to provide early risk stratification of the risk of death during hospitalization in patients with NSTEMI in the expectation of individualized therapeutic management to reduce in-hospital mortality.</p><p>In this study, the in-hospital mortality rate for non-diabetic patients with NSTEMI was 5.2% (40/774), which is similar to previously published studies (5.3-6.3%).<sup><xref rid="bibr3-10760296241276524" ref-type="bibr">3</xref>,<xref rid="bibr13-10760296241276524" ref-type="bibr">13</xref>,<xref rid="bibr14-10760296241276524" ref-type="bibr">14</xref></sup> We developed a novel nomogram model based on 6 clinical parameters (age, BUN, ALB, TG, D-dimer and Aspirin) for assessing the risk of in-hospital mortality in patients with NSTEMI. The nomogram yielded satisfactory discrimination power, with AUC value of 0.89 (95% CI: 0.84-0.94). The GiViTI calibration plot demonstrated the good calibration of the nomogram and the DCA showed that the nomogram has good practical value.</p><p>It is well known that advanced age is both an important risk factor for heart disease and an influential factor in poor prognosis. In this study, we found that advanced age was an independent predictor of in-hospital mortality in patients with NSTEMI.</p><p>BUN is a protein metabolic product generated mainly in the liver and excreted through the kidney, and traditionally, the level of serum BUN is an indicator of renal function.</p><p>BUN has been shown to be independently associated with prognosis in patients with acute myocardial infarction (AMI). A retrospective analysis of 2995 AMI patients by Horiuchi et al found that a high level of BUN was independently and positively associated with the risk of in-hospital mortality in patients.<sup>
<xref rid="bibr15-10760296241276524" ref-type="bibr">15</xref>
</sup> Another study showed that elevated BUN on admission was an independent predictor of long-term mortality in patients with STEMI.<sup>
<xref rid="bibr16-10760296241276524" ref-type="bibr">16</xref>
</sup> Consistent with these studies, we found that a higher level of BUN was associated with higher in-hospital mortality in patients with NSTEMI.</p><p>Several previous studies have shown that low serum ALB is associated with poor in-hospital outcomes and long-term prognosis in patients with coronary artery disease (CAD).<sup><xref rid="bibr17-10760296241276524" ref-type="bibr">17</xref><xref rid="bibr18-10760296241276524" ref-type="bibr"/>&#8211;<xref rid="bibr19-10760296241276524" ref-type="bibr">19</xref></sup> Similar results were obtained in the present study, where we found that for every 1&#8197;g/L decrease in serum ALB, there was a corresponding 7% increase in the risk of in-hospital death in patients with NSTEMI. This may be related to the fact that ALB is a negative acute phase reactant, whose synthesis decreases and catabolism increases in some cases of inflammation-related diseases such as AMI.<sup>
<xref rid="bibr20-10760296241276524" ref-type="bibr">20</xref>
</sup></p><p>A study from China that included 5836 AMI patients identified D-dimer as a strong predictor of in-hospital death,<sup>
<xref rid="bibr21-10760296241276524" ref-type="bibr">21</xref>
</sup> which is consistent with our findings. Interestingly, however, the analysis of another study that included 234 Turkish patients hospitalized with NSTEMI showed that D-dimer had no significant value in predicting the risk of death.<sup>
<xref rid="bibr22-10760296241276524" ref-type="bibr">22</xref>
</sup> We hypothesize that this opposite finding may be due to the small relative sample size of the latter.</p><p>The results of existing studies on the effect of serum TG levels on cardiovascular prognosis are inconsistent. In a cohort study of 1836 Japanese patients with CAD undergoing complete revascularisation, Kasai et al found that elevated fasting TG level is associated with increased risk of cardiac death.<sup>
<xref rid="bibr23-10760296241276524" ref-type="bibr">23</xref>
</sup> Similarly, we found that TG was strongly associated with in-hospital death, with a 41% increase in the risk of in-hospital death per 1&#8197;mmol/L increase in TG. However, other studies have suggested that lower TG on admission is associated with a poorer short- and long-term prognosis in patients with CAD.<sup><xref rid="bibr24-10760296241276524" ref-type="bibr">24</xref>,<xref rid="bibr25-10760296241276524" ref-type="bibr">25</xref></sup> High TG level is generally recognized as a risk factor for cardiovascular disease, yet it is associated with a poor cardiovascular prognosis, a phenomenon Xia et al refer to as a &#8220;TG paradox&#8221; and suggest that this may be because high TG levels indicate a better overall nutritional status, and thus a better prognosis for the patient.<sup>
<xref rid="bibr26-10760296241276524" ref-type="bibr">26</xref>
</sup></p><p>Aspirin has a wide application worldwide as a basic drug in the treatment of NSTEMI. As shown in <xref rid="table1-10760296241276524" ref-type="table">Table 1</xref>, in our study, a significantly lower proportion of NSTEMI patients who died in-hospital used aspirin compared to those who survived to discharge (70% vs 96.7%, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). There was no indication in the original study as to why individual patients did not use aspirin, and we speculate that this may be related to the risk of bleeding. Our study showed that aspirin use significantly reduced in-hospital mortality.</p><p>In this study, we developed a nomogram model for predicting in-hospital mortality in patients with NSTEMI. The nomogram showed good predictive performance and clinical utility. The predictors in the nomogram are readily available, which greatly extends its applicability and allows physicians to use the model to quickly and accurately determine the risk of in-hospital death in patients with NSTEMI and provide timely treatment to reduce mortality.</p><p>This study also has some limitations. Firstly, although the prediction model developed in this study was internally validated and performed well, it lacked external validation. Secondly, prospective studies and larger sample sizes are needed to validate the results. Finally, this was a retrospective and observational study and although we performed a multivariate analysis to eliminate confounding factors, there may still be bias due to unknown confounders.</p></sec><sec sec-type="conclusions" id="section5-10760296241276524"><title>Conclusions</title><p>In this study, we developed a nomogram model for predicting in-hospital mortality in patients with NSTEMI based on common clinical indicators. The prediction model was validated to have good discrimination, calibration and clinical utility. The model allows for rapid risk stratification of NSTEMI patients and provides a basis for individualized treatment.</p><p>limitations of the study. The present study was a secondary analysis based on the original study, which inevitably had some limitations due to the availability of primary data, such as our inability to obtain exhaustive patient history, in-hospital complications, electrocardiograms, coronary angiograms, and catheterization information. Therefore, larger prospective cohort studies are needed to confirm the findings of this study before the results can be generalized.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Dr Yao from Zhongda Hospital affiliated to Southeast University for sharing the data.</p></ack><fn-group><fn fn-type="con"><p><bold>Author Contributions:</bold> Wei Hu designed the study. Panpan Li wrote the manuscript, which was revised and statistically supervised by Wensen Yao. Jingjing Wu, Yating Gao, and Xueyuan Zhang participated in the analysis of the data.</p></fn><fn fn-type="other"><p><bold>Data Sharing Statement:</bold> The raw data can be obtained from the following website: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://peerj.com/articles/14346/" ext-link-type="uri">https://peerj.com/articles/14346/</ext-link></p></fn><fn fn-type="COI-statement"><p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="other"><p><bold>Ethics Approval:</bold> The Ethics Committee of Zhongda Hospital affiliated to Southeast University (2020ZDSYLL164-P01) approved the original study.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Xiaogan Natural Science Program (XGKJ2020010005); Hubei Provincial Health Commission Joint Fund (WJ2018H0094); Hubei Provincial Key Laboratory of Occupational Hazard Identification and Control (JF2023-G10).</p></fn><fn fn-type="other"><p><bold>ORCID iDs:</bold> Panpan Li <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0001-0203-6547" ext-link-type="uri">https://orcid.org/0009-0001-0203-6547</ext-link></p><p>Wensen Yao <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0001-7151-4293" ext-link-type="uri">https://orcid.org/0000-0001-7151-4293</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-10760296241276524"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>SS</given-names></name><name name-style="western"><surname>Aday</surname><given-names>AW</given-names></name><name name-style="western"><surname>Almarzooq</surname><given-names>ZI</given-names></name></person-group>, <etal>et al.</etal><article-title>2024 Heart disease and stroke statistics: A report of US and global data from the American Heart Association</article-title>. <source>Circulation</source>. <year>2024</year>;<volume>149</volume>(<issue>8</issue>):<comment>e347</comment>&#8208;<lpage>e913</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000001209</pub-id><pub-id pub-id-type="pmcid">PMC12146881</pub-id><pub-id pub-id-type="pmid">38264914</pub-id></mixed-citation></ref><ref id="bibr2-10760296241276524"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fanaroff</surname><given-names>AC</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>ED</given-names></name><name name-style="western"><surname>Chen</surname><given-names>AY</given-names></name></person-group>, <etal>et al.</etal><article-title>Intensive care unit utilization and mortality among medicare patients hospitalized with non-ST-segment elevation myocardial infarction</article-title>. <source>JAMA cardiology</source>. <year>2017</year>;<volume>2</volume>(<issue>1</issue>):<fpage>36</fpage>&#8208;<lpage>44</lpage>.<pub-id pub-id-type="pmid">27806171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamacardio.2016.3855</pub-id><pub-id pub-id-type="pmcid">PMC5776676</pub-id></mixed-citation></ref><ref id="bibr3-10760296241276524"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D</given-names></name><name name-style="western"><surname>Xie</surname><given-names>W</given-names></name></person-group><etal>,</etal><etal>et al.</etal><article-title>Recent trends in hospitalization for acute myocardial infarction in Beijing: Increasing overall burden and a transition from ST-segment elevation to non-ST-segment elevation myocardial infarction in a population-based study</article-title>. <source>Medicine (Baltimore)</source>. <year>2016</year>;<volume>95</volume>(<issue>5</issue>):<comment>e2677</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000002677</pub-id><pub-id pub-id-type="pmcid">PMC4748920</pub-id><pub-id pub-id-type="pmid">26844503</pub-id></mixed-citation></ref><ref id="bibr4-10760296241276524"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name></person-group>, <etal>et al.</etal><article-title>Case fatality rate of patients with acute myocardial infarction in 253 chest pain centers - China, 2019-2020</article-title>. <source>China CDC weekly</source>. <year>2022</year>;<volume>4</volume>(<issue>24</issue>):<fpage>518</fpage>&#8208;<lpage>521</lpage>.<pub-id pub-id-type="pmid">35812700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.46234/ccdcw2022.026</pub-id><pub-id pub-id-type="pmcid">PMC9257690</pub-id></mixed-citation></ref><ref id="bibr5-10760296241276524"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amsterdam</surname><given-names>EA</given-names></name><name name-style="western"><surname>Wenger</surname><given-names>NK</given-names></name><name name-style="western"><surname>Brindis</surname><given-names>RG</given-names></name></person-group>, <etal>et al.</etal><article-title>2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: Executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines</article-title>. <source>Circulation</source>. <year>2014</year>;<volume>130</volume>(<issue>25</issue>):<fpage>2354</fpage>&#8208;<lpage>2394</lpage>.<pub-id pub-id-type="pmid">25249586</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000000133</pub-id></mixed-citation></ref><ref id="bibr6-10760296241276524"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antman</surname><given-names>EM</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernink</surname><given-names>PJ</given-names></name></person-group><etal>, et al.</etal><article-title>The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making</article-title>. <source>Jama</source>. <year>2000</year>;<volume>284</volume>(<issue>7</issue>):<fpage>835</fpage>&#8208;<lpage>842</lpage>.<pub-id pub-id-type="pmid">10938172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.284.7.835</pub-id></mixed-citation></ref><ref id="bibr7-10760296241276524"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>KA</given-names></name><name name-style="western"><surname>Dabbous</surname><given-names>OH</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>RJ</given-names></name></person-group>, <etal>et al.</etal><article-title>Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE)</article-title>. <source>BMJ (Clinical research ed)</source>. <year>2006</year>;<volume>333</volume>(<issue>7578</issue>):<fpage>1091</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.38985.646481.55</pub-id><pub-id pub-id-type="pmcid">PMC1661748</pub-id><pub-id pub-id-type="pmid">17032691</pub-id></mixed-citation></ref><ref id="bibr8-10760296241276524"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiele</surname><given-names>F</given-names></name><name name-style="western"><surname>Meneveau</surname><given-names>N</given-names></name></person-group>. <article-title>NSTEMI Management: A fall from GRACE?</article-title><source>Eur Heart J</source>. <year>2022</year>;<volume>43</volume>(<issue>24</issue>):<fpage>2300</fpage>&#8208;<lpage>2302</lpage>.<pub-id pub-id-type="pmid">35254420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehac027</pub-id></mixed-citation></ref><ref id="bibr9-10760296241276524"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yanqiao</surname><given-names>L</given-names></name><name name-style="western"><surname>Shen</surname><given-names>L</given-names></name><name name-style="western"><surname>Yutong</surname><given-names>M</given-names></name><name name-style="western"><surname>Linghong</surname><given-names>S</given-names></name><name name-style="western"><surname>Ben</surname><given-names>H</given-names></name></person-group>. <article-title>Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among east Asian non-ST-elevation myocardial infarction patients</article-title>. <source>BMC Cardiovasc Disord</source>. <year>2022</year>;<volume>22</volume>(<issue>1</issue>):<fpage>4</fpage>.<pub-id pub-id-type="pmid">34996365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12872-021-02311-z</pub-id><pub-id pub-id-type="pmcid">PMC8742311</pub-id></mixed-citation></ref><ref id="bibr10-10760296241276524"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>R</given-names></name><name name-style="western"><surname>Song</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name></person-group>, <etal>et al.</etal><article-title>CAMI-NSTEMI Score&#12288;- China acute myocardial infarction registry-derived novel tool to predict in-hospital death in non-ST segment elevation myocardial infarction patients</article-title>. <source>Circ J</source>. <year>2018</year>;<volume>82</volume>(<issue>7</issue>):<fpage>1884</fpage>&#8208;<lpage>1891</lpage>.<pub-id pub-id-type="pmid">29887577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1253/circj.CJ-17-1078</pub-id></mixed-citation></ref><ref id="bibr11-10760296241276524"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Z</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>A</given-names></name></person-group><etal>,</etal><etal>et al.</etal><article-title>The triglycerides-glucose index and the triglycerides to high-density lipoprotein cholesterol ratio are both effective predictors of in-hospital death in non-diabetic patients with AMI</article-title>. <source>PeerJ</source>. <year>2022</year>;<volume>10</volume>:<comment>e14346</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7717/peerj.14346</pub-id><pub-id pub-id-type="pmcid">PMC9686411</pub-id><pub-id pub-id-type="pmid">36438585</pub-id></mixed-citation></ref><ref id="bibr12-10760296241276524"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitsis</surname><given-names>A</given-names></name><name name-style="western"><surname>Gragnano</surname><given-names>F</given-names></name></person-group>. <article-title>Myocardial infarction with and without ST-segment elevation: A contemporary reappraisal of similarities and differences</article-title>. <source>Curr Cardiol Rev</source>. <year>2021</year>;<volume>17</volume>(<issue>4</issue>):<comment>e230421189013</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1573403X16999201210195702</pub-id><pub-id pub-id-type="pmcid">PMC8762150</pub-id><pub-id pub-id-type="pmid">33305709</pub-id></mixed-citation></ref><ref id="bibr13-10760296241276524"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sawayama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takashima</surname><given-names>N</given-names></name><name name-style="western"><surname>Harada</surname><given-names>A</given-names></name></person-group>, <etal>et al.</etal><article-title>Incidence and in-hospital mortality of acute myocardial infarction: A report from a population-based registry in Japan</article-title>. <source>J Atheroscler Thromb</source>. <year>2023</year>;<volume>30</volume>(<issue>10</issue>):<fpage>1407</fpage>&#8208;<lpage>1419</lpage>.<pub-id pub-id-type="pmid">36596530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5551/jat.63888</pub-id><pub-id pub-id-type="pmcid">PMC10564630</pub-id></mixed-citation></ref><ref id="bibr14-10760296241276524"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alves</surname><given-names>L</given-names></name><name name-style="western"><surname>Ziegelmann</surname><given-names>PK</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>V</given-names></name><name name-style="western"><surname>Polanczyk</surname><given-names>C</given-names></name></person-group>. <article-title>Hospital mortality from myocardial infarction in Latin America and the Caribbean: Systematic review and meta-analysis</article-title>. <source>Arq Bras Cardiol</source>. <year>2022</year>;<volume>119</volume>(<issue>6</issue>):<fpage>970</fpage>&#8208;<lpage>978</lpage>.<pub-id pub-id-type="pmid">36541993</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.36660/abc.20220194</pub-id><pub-id pub-id-type="pmcid">PMC9814809</pub-id></mixed-citation></ref><ref id="bibr15-10760296241276524"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horiuchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>J</given-names></name><name name-style="western"><surname>Tanabe</surname><given-names>K</given-names></name></person-group>, <etal>et al.</etal><article-title>A high level of blood urea nitrogen is a significant predictor for in-hospital mortality in patients with acute myocardial infarction</article-title>. <source>Int Heart J</source>. <year>2018</year>;<volume>59</volume>(<issue>2</issue>):<fpage>263</fpage>&#8208;<lpage>271</lpage>.<pub-id pub-id-type="pmid">29459576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1536/ihj.17-009</pub-id></mixed-citation></ref><ref id="bibr16-10760296241276524"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aronson</surname><given-names>D</given-names></name><name name-style="western"><surname>Hammerman</surname><given-names>H</given-names></name><name name-style="western"><surname>Beyar</surname><given-names>R</given-names></name></person-group><etal>,</etal><etal>et al.</etal><article-title>Serum blood urea nitrogen and long-term mortality in acute ST-elevation myocardial infarction</article-title>. <source>Int J Cardiol</source>. <year>2008</year>;<volume>127</volume>(<issue>3</issue>):<fpage>380</fpage>&#8208;<lpage>385</lpage>.<pub-id pub-id-type="pmid">17765341</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijcard.2007.05.013</pub-id></mixed-citation></ref><ref id="bibr17-10760296241276524"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshioka</surname><given-names>G</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>A</given-names></name><name name-style="western"><surname>Nishihira</surname><given-names>K</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Node</surname><given-names>K</given-names></name></person-group>. <article-title>Prognostic impact of serum albumin for developing heart failure remotely after acute myocardial infarction</article-title>. <source>Nutrients</source>. <year>2020</year>;<volume>12</volume>(<issue>9</issue>):<fpage>2637</fpage>.<pub-id pub-id-type="pmid">32872477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nu12092637</pub-id><pub-id pub-id-type="pmcid">PMC7551643</pub-id></mixed-citation></ref><ref id="bibr18-10760296241276524"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>CW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CW</given-names></name><name name-style="western"><surname>Chien</surname><given-names>SC</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>HI</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CY</given-names></name></person-group>. <article-title>Serum albumin was associated with a long term cardiovascular mortality among elderly patients with stable coronary artery disease</article-title>. <source>Acta Cardiologica Sinica</source>. <year>2024</year>;<volume>40</volume>(<issue>1</issue>):<fpage>87</fpage>&#8208;<lpage>96</lpage>.<pub-id pub-id-type="pmid">38264075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.6515/ACS.202401_40(1).20230825A</pub-id><pub-id pub-id-type="pmcid">PMC10801420</pub-id></mixed-citation></ref><ref id="bibr19-10760296241276524"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>MS</given-names></name><name name-style="western"><surname>Islam</surname><given-names>MN</given-names></name><name name-style="western"><surname>Kundu</surname><given-names>SK</given-names></name></person-group>, <etal>et al.</etal><article-title>Serum albumin level and in-hospital outcome of patients with first attack acute myocardial infarction</article-title>. <source>Mymensingh Medical Journal : MMJ</source>. <year>2019</year>;<volume>28</volume>(<issue>4</issue>):<fpage>744</fpage>&#8208;<lpage>751</lpage>.<pub-id pub-id-type="pmid">31599236</pub-id></mixed-citation></ref><ref id="bibr20-10760296241276524"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sevd&#305;mbas</surname><given-names>S</given-names></name><name name-style="western"><surname>Satar</surname><given-names>S</given-names></name><name name-style="western"><surname>Gulen</surname><given-names>M</given-names></name></person-group><etal>,</etal><etal>et al.</etal><article-title>Blood urea nitrogen/albumin ratio on admission predicts mortality in patients with non ST segment elevation myocardial infarction</article-title>. <source>Scand J Clin Lab Invest</source>. <year>2022</year>;<volume>82</volume>(<issue>6</issue>):<fpage>454</fpage>&#8208;<lpage>460</lpage>.<pub-id pub-id-type="pmid">36128642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00365513.2022.2122075</pub-id></mixed-citation></ref><ref id="bibr21-10760296241276524"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xie</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name></person-group>. <article-title>Machine learning in the prediction of in-hospital mortality in patients with first acute myocardial infarction</article-title>. <source>Clin Chim Acta</source>. <year>2024</year>;<volume>554</volume>:<fpage>117776</fpage>.<pub-id pub-id-type="pmid">38216028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cca.2024.117776</pub-id></mixed-citation></ref><ref id="bibr22-10760296241276524"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satilmisoglu</surname><given-names>MH</given-names></name><name name-style="western"><surname>Ozyilmaz</surname><given-names>SO</given-names></name><name name-style="western"><surname>Gul</surname><given-names>M</given-names></name></person-group><etal>, et al.</etal><article-title>Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction</article-title>. <source>Ther Clin Risk Manag</source>. <year>2017</year>;<volume>13</volume>:<fpage>393</fpage>&#8208;<lpage>400</lpage>.<pub-id pub-id-type="pmid">28408834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/TCRM.S124794</pub-id><pub-id pub-id-type="pmcid">PMC5384739</pub-id></mixed-citation></ref><ref id="bibr23-10760296241276524"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kasai</surname><given-names>T</given-names></name><name name-style="western"><surname>Miyauchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>N</given-names></name></person-group><etal>, et al.</etal><article-title>Mortality risk of triglyceride levels in patients with coronary artery disease</article-title>. <source>Heart (British Cardiac Society)</source>. <year>2013</year>;<volume>99</volume>(<issue>1</issue>):<fpage>22</fpage>&#8208;<lpage>29</lpage>.<pub-id pub-id-type="pmid">23014481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/heartjnl-2012-302689</pub-id></mixed-citation></ref><ref id="bibr24-10760296241276524"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khawaja</surname><given-names>OA</given-names></name><name name-style="western"><surname>Hatahet</surname><given-names>H</given-names></name><name name-style="western"><surname>Cavalcante</surname><given-names>J</given-names></name><name name-style="western"><surname>Khanal</surname><given-names>S</given-names></name><name name-style="western"><surname>Al-Mallah</surname><given-names>MH</given-names></name></person-group>. <article-title>Low admission triglyceride and mortality in acute coronary syndrome patients</article-title>. <source>Cardiol J</source>. <year>2011</year>;<volume>18</volume>(<issue>3</issue>):<fpage>297</fpage>&#8208;<lpage>303</lpage>.<pub-id pub-id-type="pmid">21660920</pub-id></mixed-citation></ref><ref id="bibr25-10760296241276524"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>YT</given-names></name><name name-style="western"><surname>Liu</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Lai</surname><given-names>HC</given-names></name></person-group><etal>,</etal><etal>et al.</etal><article-title>Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study</article-title>. <source>BMC Cardiovasc Disord</source>. <year>2014</year>;<volume>14</volume>(<issue>1</issue>):<fpage>143</fpage>.<pub-id pub-id-type="pmid">25303974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2261-14-143</pub-id><pub-id pub-id-type="pmcid">PMC4197277</pub-id></mixed-citation></ref><ref id="bibr26-10760296241276524"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>TL</given-names></name><name name-style="western"><surname>Li</surname><given-names>YM</given-names></name><name name-style="western"><surname>Huang</surname><given-names>FY</given-names></name></person-group>, <etal>et al.</etal><article-title>The triglyceride paradox in the mortality of coronary artery disease</article-title>. <source>Lipids Health Dis</source>. <year>2019</year>;<volume>18</volume>(<issue>1</issue>):<fpage>21</fpage>.<pub-id pub-id-type="pmid">30670053</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-019-0972-0</pub-id><pub-id pub-id-type="pmcid">PMC6343235</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>